MATTER Spotlight: John Colson, ClostraBio

ClostraBio is harnessing the protective ability of the microbiome to advance care and improve lives for people with food allergies.

The team has developed a first-of-its kind treatment that utilizes a common class of gut bacteria to act as a barrier, preventing trigger foods from entering the bloodstream and sparking an allergic reaction.

Learn more about ClostraBio